Laboratory of Pharmacology, São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP, Brazil.
Laboratory of Pharmacology, São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP, Brazil.
Neuropharmacology. 2022 Jul 1;212:109061. doi: 10.1016/j.neuropharm.2022.109061. Epub 2022 Apr 19.
We investigated the role of corticotropin-releasing factor (CRF) neurotransmission within the lateral hypothalamus (LH) in cardiovascular and anxiogenic-like responses evoked by acute and repeated restraint stress in rats. For this, animals were subjected to intra-LH microinjection of a selective CRF (CP376395) or CRF (antisauvagine-30) receptor antagonist before either an acute or the 10th session of restraint stress. Restraint-evoked arterial pressure and heart rate increases, tail skin temperature decrease and anxiogenic-like effect in the elevated plus maze (EPM) were evaluated. We also assessed the effect of 10 daily sessions of restraint on expression of CRF and CRF receptors within the LH. We identified that antagonism of either CRF or CRF receptor within the LH decreased the tachycardia during both the acute and 10th session of restraint, but the effect of the CRF receptor antagonist was more pronounced during the 10th session. Acute restraint stress also caused anxiogenic-like effect, and this response was inhibited in animals treated with either CP376395 or antisauvagine-30. Anxiety-like behaviors were not changed following the 10th session of restraint, and pharmacological treatments did not affect the behavior in the EPM in chronically stressed animals. Repeated restraint also did not change the level of the CRF receptors within the LH. Taken together, the findings indicate that CRF and CRF receptors within the LH are involved in tachycardic and anxiogenic-like responses to aversive stimuli. Control of tachycardia by the CRF receptor is sensitized by previous stressful experience, and this effect seems to be independent of changes in expression of the receptor.
我们研究了外侧下丘脑(LH)内促肾上腺皮质释放因子(CRF)神经传递在急性和重复束缚应激引起的心血管和焦虑样反应中的作用。为此,动物在急性或第 10 次束缚应激前接受 LH 内选择性 CRF(CP376395)或 CRF(抗 Sauvagine-30)受体拮抗剂的微注射。评估束缚引起的动脉压和心率增加、尾部皮肤温度降低以及高架十字迷宫(EPM)中的焦虑样效应。我们还评估了 10 天束缚对 LH 内 CRF 和 CRF 受体表达的影响。我们发现,LH 内 CRF 或 CRF 受体的拮抗作用均可减少急性和第 10 次束缚期间的心动过速,但 CRF 受体拮抗剂的作用在第 10 次束缚期间更为明显。急性束缚应激也引起焦虑样效应,而用 CP376395 或抗 Sauvagine-30 处理的动物可抑制这种反应。第 10 次束缚后,焦虑样行为没有改变,慢性应激动物的药理学治疗也不会影响 EPM 中的行为。重复束缚也不会改变 LH 内 CRF 受体的水平。总之,这些发现表明,LH 内的 CRF 和 CRF 受体参与了对厌恶刺激的心动过速和焦虑样反应。CRF 受体对心动过速的控制在前次应激体验中被敏化,这种效应似乎与受体表达的变化无关。